Alignment Healthcare
ALHC · NYSE · Healthcare · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$3.9B
Net margin
-0.0%
ROE
-0.4%
Revenue CAGR (2y)
+48.1%
EPS (FY2025)
0.00
Net profit (FY2025)
$-724,000
Ask MarketChacha about ALHC
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Aug 4, 2026
ALHC fell on Raymond James downgrading the stock to Outperform from Strong Buy (PT cut to $19) citing reduced earnings visibility from expansion outside California and ongoing spending on growth initiatives; additional pressure came from a law firm investigation into potential securities law violations tied to accounting questions.
- Jul 27, 2026
ALHC fell amid continued investor reaction to whistleblower allegations of accounting irregularities and financial misstatements, with multiple law firms (including Kaplan Fox) issuing new investor alerts and launching investigations into potential securities violations.
- Jul 23, 2026
ALHC fell on news of Hagens Berman launching an investigation into potential securities law violations following whistleblower allegations of financial manipulation and accounting misconduct.
source 1 ↗· confidence: high - Jul 22, 2026
Alignment Healthcare shares fell on news of a Kaplan Fox investigation into potential securities law violations stemming from whistleblower claims of accounting misconduct and financial overstatement.
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $3.9B | $-724,000 | 0.00 | -0.0% | -0.4% |
| FY2024 | $2.7B | $-128.0M | -0.67 | -4.7% | -128.2% |
| FY2023 | $1.8B | $-148.0M | -0.79 | -8.2% | -94.3% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $1.3B | $36.6M | 0.17 | 2.7% |
| 2026Q1 | $1.2B | $11.4M | 0.05 | 0.9% |
| 2025Q3 | $993.7M | $3.7M | 0.02 | 0.4% |
| 2025Q2 | $1.0B | $15.7M | 0.07 | 1.5% |
| 2025Q1 | $926.9M | $-9.1M | -0.05 | -1.0% |
| 2024Q3 | $692.4M | $-26.4M | -0.14 | -3.8% |
| 2024Q2 | $681.3M | $-24.0M | -0.13 | -3.5% |
| 2024Q1 | $628.6M | $-46.5M | -0.25 | -7.4% |
| 2023Q3 | $450.2M | $-35.0M | -0.19 | -7.8% |
| 2023Q2 | $456.9M | $-28.5M | -0.15 | -6.2% |
| 2023Q1 | $434.8M | $-37.3M | -0.20 | -8.6% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC7/30/2026material
- SEC7/30/2026
- SEC6/9/2026material
- SEC5/12/2026material
- SEC4/30/2026material
- SEC4/30/2026
- SEC3/4/2026material
- SEC2/27/2026
- SEC2/26/2026material
- SEC1/12/2026material
2025
- SEC10/30/2025material
- SEC10/30/2025
- SEC9/9/2025material
- SEC7/30/2025material
- SEC7/30/2025
In the news
- Alignment Healthcare President Dawn Maroney Sells 5,000 Shares Under 10b5-1 PlanKalkine Media · 8/18/2026
- Alignment Healthcare (ALHC) president holds 917K shares after 10b5-1 saleStock Titan · 8/18/2026
- Assenagon Asset Management S.A. Reduces Stake in Alignment Healthcare, Inc. $ALHCMarketBeat · 8/16/2026
- GSA Capital Partners LLP Acquires Shares of 86,412 Alignment Healthcare, Inc. $ALHCMarketBeat · 8/16/2026
- The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognitionsimplywall.st · 8/15/2026
- Law firms probe Alignment Healthcare over alleged $10M EBITDA inflationscanx.trade · 8/14/2026
- Is Alignment Healthcare (ALHC) Undervalued Following Whistleblower Claims And Accounting Investigations?simplywall.st · 8/13/2026
- Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on Behalf of InvestorsThe Globe and Mail · 8/13/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.